富血小板血 (PRP):在人体中的分子机制,作用和临床应用
Wen-Shan Wu1, Li-Ru Chen2,3, Kuo-Hu Chen4,5
1Department of Medical Education, Taipei Tzu-Chi Hospital, The Buddhist Tzu-Chi Medical Foundation, New Taipei City 231, Taiwan.
International journal of molecular sciences
|November 13, 2025
概括
富血小板血 (PRP) 疗法使用患者自己的血度来加快愈合. 这种多功能的再生医学方法在整形外科,皮肤病学和伤口护理方面表现有前途.
科学领域:
- 再生医学是一种再生医学.
- 生物材料科学 生物材料科学
- 细胞生物学 细胞生物学
背景情况:
- 富血小板血 (PRP) 是一种用于再生医学的自身缩物.
- 根据制备方法,PRP的成分会有所不同,从而影响治疗结果.
- 关键成分包括血小板,白细胞,血蛋白和细胞外囊泡.
研究的目的:
- 审查PRP的组成,机制和临床应用.
- 突出PRP在加速组织修复和再生中的作用.
- 讨论挑战和PRP不断扩大的临床实用性.
主要方法:
- 关于PRP制备,组成和机制的文献综述.
- 分析PRP在各种医学专业中的作用.
- 对PRP疗效的临床证据的审查.
主要成果:
- PRP组件通过增长因子释放,免疫调节和脚手架协同促进愈合.
- PRP通过包括血静,免疫调节,血管生成和止痛在内的途径增强组织修复.
- 临床应用范围包括骨科,皮肤病学,妇科,牙科和慢性伤口护理.
结论:
- PRP是一种多功能疗法,可以创造一个再生的微环境.
- PRP在加速愈合和功能恢复方面显示出广泛的临床实用性.
- 标准化PRP制剂仍然是一个挑战,以获得一致的治疗结果.
相关概念视频
Structure and Function of Platelets
2.8K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
2.8K
Formation of the Platelet Plug
8.6K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.6K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.1K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.1K
Clot Retraction and Fibrinolysis
8.3K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
8.3K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Introduction to Hemostasis
13.2K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
13.2K


